<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://gxplex.org/index.php?action=history&amp;feed=atom&amp;title=TestPage_MDR</id>
	<title>TestPage MDR - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://gxplex.org/index.php?action=history&amp;feed=atom&amp;title=TestPage_MDR"/>
	<link rel="alternate" type="text/html" href="https://gxplex.org/index.php?title=TestPage_MDR&amp;action=history"/>
	<updated>2026-10-07T12:14:09Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://gxplex.org/index.php?title=TestPage_MDR&amp;diff=8930&amp;oldid=prev</id>
		<title>Gxplex admin: style: remove width:100% from wikitable</title>
		<link rel="alternate" type="text/html" href="https://gxplex.org/index.php?title=TestPage_MDR&amp;diff=8930&amp;oldid=prev"/>
		<updated>2026-06-29T13:00:49Z</updated>

		<summary type="html">&lt;p&gt;style: remove width:100% from wikitable&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{RegDocument&lt;br /&gt;
| area_of_validity  = EU&lt;br /&gt;
| scope             = MD&lt;br /&gt;
| document_type     = Regulation&lt;br /&gt;
| name              = Medical Device Regulation (EU) 2017/745&lt;br /&gt;
| version           = 2017/745, amended by 2023/607&lt;br /&gt;
| source            = https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0745&lt;br /&gt;
| language          = EN, DE, FR (all EU official languages)&lt;br /&gt;
| status            = Current&lt;br /&gt;
| restricted_access = No&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
The Medical Device Regulation (MDR) 2017/745 replaces the former Medical Device Directive (MDD 93/42/EEC) and the Active Implantable Medical Device Directive (AIMDD 90/385/EEC). It establishes a uniform regulatory framework for medical devices across EU member states, with a strong focus on clinical evidence, post-market surveillance, and traceability.&lt;br /&gt;
&lt;br /&gt;
Full application started on 26 May 2021. The amendment 2023/607 introduced a phased transition period for legacy devices.&lt;br /&gt;
&lt;br /&gt;
== Key references ==&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
! Topic / Keyword(s) !! Category / Chapter !! Scope !! Linked document !! Description&lt;br /&gt;
{{Reference&lt;br /&gt;
| topic           = Post-market surveillance, PMCF&lt;br /&gt;
| category        = Clinical&lt;br /&gt;
| scope           = MD&lt;br /&gt;
| linked_document = [[MDR 2017/745 – Articles 83–86 &amp;amp; Annex XIV Part B: Post-Market Surveillance and PMCF]]&lt;br /&gt;
| description     = Articles 83–86 define the mandatory PMS system; Annex XIV Part B specifies PMCF requirements.&lt;br /&gt;
}}&lt;br /&gt;
{{Reference&lt;br /&gt;
| topic           = Unique Device Identification, UDI, Traceability&lt;br /&gt;
| category        = Labelling&lt;br /&gt;
| scope           = MD&lt;br /&gt;
| linked_document = [[MDR 2017/745 – Articles 27–29 &amp;amp; Annex VI: Unique Device Identification (UDI)]]&lt;br /&gt;
| description     = Articles 27–29 and Annex VI establish the UDI system. All devices must carry a UDI carrier on label and packaging.&lt;br /&gt;
}}&lt;br /&gt;
{{Reference&lt;br /&gt;
| topic           = Clinical evaluation, Clinical evidence&lt;br /&gt;
| category        = Clinical&lt;br /&gt;
| scope           = MD&lt;br /&gt;
| linked_document =&lt;br /&gt;
| description     = Article 61 and Annex XIV Part A define the clinical evaluation process and documentation requirements (CER). &amp;#039;&amp;#039;Page not yet created.&amp;#039;&amp;#039;&lt;br /&gt;
}}&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Related documents ==&lt;br /&gt;
&lt;br /&gt;
* [[In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746]] – Parallel regulation for IVDs&lt;br /&gt;
&lt;br /&gt;
[[Category:Medical Devices]]&lt;br /&gt;
[[Category:EU Regulation]]&lt;/div&gt;</summary>
		<author><name>Gxplex admin</name></author>
	</entry>
</feed>